ascopubs.org

Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma.

This is an ASCO Meeting Abstract from the 2022 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text component.
Healio

Lowering phosphorus food additive intake may reduce fibroblast growth factor 23 level

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Mean 24-hour urine phosphorus excretion decreased by 30% ...
University of Geneva

NGF pathway drives tumour growth

NGF pathway drives tumour growth. Innate lymphoid cells type 2 (ILC2s) are key regulators of tissue homeostasis and inflammation. In cancer, ILC2s can exhibit pro-tumoral function ...
Science Daily

Extracellular matrix guides growth and function of epithelial cells

Scientists have found an essential factor from the extracellular matrix that regulates functionality of the breast tissue for instance during pregnancy. Scientists at the University of Helsinki have ...
ascopubs.org

Pivotal single-arm, phase 2 trial of tasurgratinib for patients with fibroblast growth factor receptor (FGFR)-2 gene fusion-positive cholangiocarcinoma (CCA).

Results from a phase 2 study of triplet blockade of the IL-27, PD-(L)1, and VEGF pathways with casdozokitug (casdozo, SRF388) in combination with atezolizumab (atezo) and bevacizumab (bev) in patients ...